Global Patient Recruitment for Clinical Trials Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Patient Recruitment for Clinical Trials Market Research Report 2024
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients for your trial. The global market has noticed significant growth owing to the increasing rate of clinical trials, and the rapid growth of the medical and pharmaceutical industries.
According to MRAResearch’s new survey, global Patient Recruitment for Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Patient Recruitment for Clinical Trials market research.
Key companies engaged in the Patient Recruitment for Clinical Trials industry include Antidote, Clara Health, Clariness, BBK Worldwide, Worldwide Clinical Trials, Clinical Site Services (CCSi), IQVIA, PPD Inc and Veristat, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Patient Recruitment for Clinical Trials were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Patient Recruitment for Clinical Trials market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Patient Recruitment for Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Antidote
Clara Health
Clariness
BBK Worldwide
Worldwide Clinical Trials
Clinical Site Services (CCSi)
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Praxis
MMG
Science37
StudyKIK
Global AES
TrialSpark
WCG ThreeWire
Trialfacts
Shanghai Jsure
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Endocrine
Anti-Infective
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Patient Recruitment for Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Patient Recruitment for Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Patient Recruitment for Clinical Trials market research.
Key companies engaged in the Patient Recruitment for Clinical Trials industry include Antidote, Clara Health, Clariness, BBK Worldwide, Worldwide Clinical Trials, Clinical Site Services (CCSi), IQVIA, PPD Inc and Veristat, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Patient Recruitment for Clinical Trials were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Patient Recruitment for Clinical Trials market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Patient Recruitment for Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Antidote
Clara Health
Clariness
BBK Worldwide
Worldwide Clinical Trials
Clinical Site Services (CCSi)
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Praxis
MMG
Science37
StudyKIK
Global AES
TrialSpark
WCG ThreeWire
Trialfacts
Shanghai Jsure
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Endocrine
Anti-Infective
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Patient Recruitment for Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source